Copper compound could form basis for first Lou Gehrig's disease therapy

June 13, 2014 3:16 PM

6 0

Copper compound could form basis for first Lou Gehrig's disease therapy

Friday 13 June 2014 - 8am PST

Lou Gehrig's disease - also known as amyotrophic lateral sclerosis - is an incurable, fatal disease that affects as many as 30,000 individuals in the US. But a new study published in the Journal of Neuroscience suggests a copper compound could be used in therapy for the condition.

Read more

To category page

Loading...